SUBSCRIBE
SUBSCRIBE
News   Drug Development

Active Biotech AB Year-End Report January-December 2005

February 16, 2006 | 
1 min read
* Positive results reported for all projects in 2005 * Progress in the mode of action project regarding quinoline substances
Clinical research Phase II Phase III Europe
MORE ON THIS TOPIC
Illustration showing hurdles along a path ending in an arrow
Multiple sclerosis
Sanofi’s MS Drug Fails Phase III Trial, While FDA Again Delays Approval Application
December 15, 2025
 · 
2 min read
 · 
Annalee Armstrong
vintage rocket takes flight with uncertain trajectory, concrete background. false start concept. 3d render.
Clinical research
‘Au Revoir TIGIT’: Gilead, Arcus Cut Gastro Cancer Drug After Late-Stage Failure
December 12, 2025
 · 
3 min read
 · 
Annalee Armstrong
Close-Up Of Syringe With Bottles Against Blue Background
Vaccines
CDC Highlights Efficacy of COVID-19 Shots in Kids Amid FDA Probe of Alleged Deaths
December 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Hand holds a cut-out puzzle piece shaped like a human brain, backlit by sunlight against a bright yellow background, symbolizing creativity and problem-solving.
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
December 11, 2025
 · 
1 min read
 · 
Annalee Armstrong